# EDGAR Filing Document

**Accession Number:** 0000799295
**File Stem:** 0001775697-23-000110
**Filing Date:** 2023-2
**Character Count:** 53370
**Document Hash:** b63c6c1cdbe1c4fab9646e4958234631
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001775697-23-000110.hdr.sgml**: 20230224

**ACCESSION NUMBER**: 0001775697-23-000110

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230224

**DATE AS OF CHANGE**: 20230224

**PERIOD START**: 20230930

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon Investment Funds I
- **CENTRAL INDEX KEY:** 0000799295
- **IRS NUMBER:** 043106135
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-04813
- **FILM NUMBER:** 23664524

**BUSINESS ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 212-922-6400

**MAIL ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DREYFUS INVESTMENT FUNDS
- **DATE OF NAME CHANGE:** 20081201

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MELLON INSTITUTIONAL FUNDS INVESTMENT TRUST
- **DATE OF NAME CHANGE:** 20030707

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** STANDISH AYER & WOOD INVESTMENT TRUST
- **DATE OF NAME CHANGE:** 19920703

## Series and Classes Contracts Data

### BNY Mellon Small/Mid Cap Growth Fund (Series ID: S000011499)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000031760 | Class I      | SDSCX           |
| C000075527 | Class A      | DBMAX           |
| C000075528 | Class C      | DBMCX           |
| C000130460 | Class Y      | DBMYX           |
| C000193013 | Class Z      | DBMZX           |

## Nport-Ex

STATEMENT OF INVESTMENTS<br>BNY Mellon Small/Mid Cap Growth Fund

December 31, 2022 (Unaudited)

---

| | | | |
|:---|:---|:---|:---|
| Description | Shares |  | Value ($) |
| **Common Stocks - 92.6%**  |  |  |  |
| **Capital Goods - 7.3%** |  |  |  |
| Armstrong World Industries Inc. | 379725 |  | 26045338 |
| Curtiss-Wright Corp. | 180891 |  | 30206988 |
| Fluor Corp. | 1024368 | <sup>a,b</sup>  | 35504595 |
| Graco Inc. | 333354 |  | 22421390 |
| Mercury Systems Inc. | 769919 | <sup>a,b</sup>  | 34446176 |
| SiteOne Landscape Supply Inc. | 96220 | <sup>a,b</sup>  | 11288530 |
| The AZEK Company | 513963 | <sup>a,b</sup>  | 10443728 |
| Zurn Elkay Water Solutions Corp. | 451294 |  | 9544868 |
|  |  |  | **179901613** |
| **Commercial & Professional Services - 4.3%** |  |  |  |
| CACI International Inc., Cl. A | 148185 | <sup>b</sup>  | 44542929 |
| Clarivate PLC | 1344385 | <sup>b</sup>  | 11212171 |
| CoStar Group Inc. | 328229 | <sup>b</sup>  | 25365537 |
| FTI Consulting Inc. | 152354 | <sup>b</sup>  | 24193815 |
|  |  |  | **105314452** |
| **Consumer Durables & Apparel - 2.7%** |  |  |  |
| Lululemon Athletica Inc. | 122532 | <sup>b</sup>  | 39256802 |
| Peloton Interactive Inc., Cl. A | 3337805 | <sup>a,b</sup>  | 26502172 |
|  |  |  | **65758974** |
| **Consumer Services - 5.5%** |  |  |  |
| European Wax Center Inc., Cl. A | 565615 | <sup>a,b</sup>  | 7041907 |
| Expedia Group Inc. | 480960 | <sup>b</sup>  | 42132096 |
| Planet Fitness Inc., Cl. A | 1081614 | <sup>b</sup>  | 85231183 |
|  |  |  | **134405186** |
| **Diversified Financials - 2.9%** |  |  |  |
| Ares Management Corp., Cl. A | 273835 |  | 18741267 |
| Morningstar Inc. | 144628 |  | 31324979 |
| Tradeweb Markets Inc., Cl. A | 328998 |  | 21361840 |
|  |  |  | **71428086** |
| **Energy - 6.3%** |  |  |  |
| Cactus Inc., Cl. A | 1152119 |  | 57905501 |
| EQT Corp. | 1996270 |  | 67533814 |
| PBF Energy Inc., Cl. A | 734970 |  | 29972077 |
|  |  |  | **155411392** |
| **Food & Staples Retailing - 2.1%** |  |  |  |
| Grocery Outlet Holding Corp. | 1757945 | <sup>b</sup>  | **51314415** |
| **Food, Beverage & Tobacco - 1.5%** |  |  |  |
| Freshpet Inc. | 714599 | <sup>a,b</sup>  | **37709389** |

---

------

*STATEMENT OF INVESTMENTS (Unaudited) (continued)*

---

| | | | |
|:---|:---|:---|:---|
| Description | Shares |  | Value ($) |
| **Common Stocks - 92.6% (continued)** |  |  |  |
| **Health Care Equipment & Services - 11.0%** |  |  |  |
| 1Life Healthcare Inc. | 1575410 | <sup>b</sup>  | 26325101 |
| Align Technology Inc. | 269997 | <sup>b</sup>  | 56942367 |
| DexCom Inc. | 737682 | <sup>b</sup>  | 83535110 |
| Inspire Medical Systems Inc. | 96250 | <sup>b</sup>  | 24243450 |
| Insulet Corp. | 64768 | <sup>b</sup>  | 19067052 |
| Outset Medical Inc. | 467765 | <sup>b</sup>  | 12077692 |
| Privia Health Group Inc. | 1616137 | <sup>a,b</sup>  | 36702471 |
| R1 RCM Inc. | 989752 | <sup>a,b</sup>  | 10837784 |
|  |  |  | **269731027** |
| **Materials - 1.9%** |  |  |  |
| Alcoa Corp. | 560302 |  | 25476932 |
| Constellium SE | 1804001 | <sup>b</sup>  | 21341332 |
|  |  |  | **46818264** |
| **Media & Entertainment - 2.7%** |  |  |  |
| Liberty Media Corp-Liberty Formula One, Cl. C | 690528 | <sup>b</sup>  | 41279764 |
| Live Nation Entertainment Inc. | 345955 | <sup>b</sup>  | 24126902 |
|  |  |  | **65406666** |
| **Pharmaceuticals Biotechnology & Life Sciences - 18.9%** |  |  |  |
| 10X Genomics Inc., CI. A | 309988 | <sup>b</sup>  | 11295963 |
| Ascendis Pharma A/S, ADR | 185027 | <sup>a,b</sup>  | 22597348 |
| Beam Therapeutics Inc. | 146289 | <sup>a,b</sup>  | 5721363 |
| BioMarin Pharmaceutical Inc. | 135507 | <sup>b</sup>  | 14023619 |
| Bio-Techne Corp. | 464051 |  | 38460547 |
| Cytokinetics Inc. | 277377 | <sup>a,b</sup>  | 12709414 |
| Denali Therapeutics Inc. | 651477 | <sup>b</sup>  | 18117575 |
| Horizon Therapeutics PLC | 696704 | <sup>b</sup>  | 79284915 |
| Insmed Inc. | 544661 | <sup>b</sup>  | 10882327 |
| Karuna Therapeutics Inc. | 60584 | <sup>b</sup>  | 11904756 |
| Kymera Therapeutics Inc. | 561008 | <sup>b</sup>  | 14002760 |
| Neurocrine Biosciences Inc. | 353100 | <sup>b</sup>  | 42174264 |
| PTC Therapeutics Inc. | 465336 | <sup>b</sup>  | 17761875 |
| Repligen Corp. | 253087 | <sup>a,b</sup>  | 42850160 |
| Sarepta Therapeutics Inc. | 756269 | <sup>b</sup>  | 97997337 |
| Twist Bioscience Corp. | 381918 | <sup>b</sup>  | 9093468 |
| Ultragenyx Pharmaceutical Inc. | 290227 | <sup>b</sup>  | 13446217 |
|  |  |  | **462323908** |
| **Retailing - 6.8%** |  |  |  |
| Burlington Stores Inc. | 121811 | <sup>b</sup>  | 24698398 |
| Chewy Inc., Cl. A | 661803 | <sup>a,b</sup>  | 24539655 |
| Farfetch Ltd., Cl. A | 4355596 | <sup>a,b</sup>  | 20601969 |
| National Vision Holdings Inc. | 1108209 | <sup>a,b</sup>  | 42954181 |
| Ollie's Bargain Outlet Holdings Inc. | 1170705 | <sup>b</sup>  | 54835822 |
|  |  |  | **167630025** |

---

------

---

| | | | |
|:---|:---|:---|:---|
| Description | Shares |  | Value ($) |
| **Common Stocks - 92.6% (continued)** |  |  |  |
| **Semiconductors & Semiconductor Equipment - 2.3%** |  |  |  |
| Power Integrations Inc. | 472637 |  | 33897526 |
| Semtech Corp. | 740142 | <sup>b</sup>  | 21234674 |
|  |  |  | **55132200** |
| **Software & Services - 12.5%** |  |  |  |
| AvidXchange Holdings Inc. | 517628 | <sup>b</sup>  | 5145222 |
| Bill.com Holdings Inc. | 302217 | <sup>b</sup>  | 32929564 |
| Block Inc. | 289334 | <sup>b</sup>  | 18181749 |
| DigitalOcean Holdings Inc. | 576726 | <sup>a,b</sup>  | 14689211 |
| DocuSign Inc. | 121716 | <sup>b</sup>  | 6745501 |
| DoubleVerify Holdings Inc. | 709426 | <sup>b</sup>  | 15578995 |
| Euronet Worldwide Inc. | 379866 | <sup>b</sup>  | 35851753 |
| Everbridge Inc. | 369805 | <sup>b</sup>  | 10938832 |
| HubSpot Inc. | 171425 | <sup>b</sup>  | 49564110 |
| nCino Inc. | 319062 | <sup>a,b</sup>  | 8435999 |
| Shopify Inc., Cl. A | 785574 | <sup>b</sup>  | 27267274 |
| Splunk Inc. | 236225 | <sup>b</sup>  | 20336610 |
| Twilio Inc., Cl. A | 1212562 | <sup>b</sup>  | 59367036 |
|  |  |  | **305031856** |
| **Technology Hardware & Equipment - 3.5%** |  |  |  |
| Calix Inc. | 514794 | <sup>b</sup>  | 35227353 |
| Lumentum Holdings Inc. | 409390 | <sup>b</sup>  | 21357876 |
| nLight Inc. | 602269 | <sup>b</sup>  | 6107008 |
| Trimble Inc. | 251911 | <sup>b</sup>  | 12736620 |
| Zebra Technologies Corp., Cl. A | 37876 | <sup>b</sup>  | 9711785 |
|  |  |  | **85140642** |
| **Telecommunication Services - .4%** |  |  |  |
| Bandwidth Inc., Cl. A | 443755 | <sup>b</sup>  | **10184177** |
| **Total Common Stocks** (cost $1,959,911,022) |  |  | **2268642272** |
| **Private Equity - .6%**  |  |  |  |
| **Diversified Financials - .1%** |  |  |  |
| Fundbox | 702664 | <sup>b,c</sup>  | **2649043** |
| **Pharmaceuticals Biotechnology & Life Sciences - .2%** |  |  |  |
| Aspen Neuroscience | 1963167 | <sup>b,c</sup>  | **3965597** |
| **Real Estate - .2%** |  |  |  |
| Roofstock | 346123 | <sup>b,c</sup>  | **3859272** |
| **Software & Services - .1%** |  |  |  |
| Locus Robotics | 101086 | <sup>b,c</sup>  | **3786682** |
| **Total Private Equity** (cost $30,174,132) |  |  | **14260594** |

---

------

*STATEMENT OF INVESTMENTS (Unaudited) (continued)*

---

| | | | |
|:---|:---|:---|:---|
|  |  | Number of Rights |  |
| **Rights - .0%**  | **Rights - .0%**  |  |  |
| **Health Care Equipment & Services - .0%** | **Health Care Equipment & Services - .0%** |  |  |
| Abiomed Inc. expiring 12/31/2023<br>(cost $0) |  | 160644<br> <sup>c</sup>  | **163857** |
|  | 1-Day<br>Yield (%) |  |  |
| **Investment Companies - 6.9%**  | **Investment Companies - 6.9%**  |  |  |
| **Registered Investment Companies - 6.9%** | **Registered Investment Companies - 6.9%** |  |  |
| Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional Shares<br>(cost $168,815,139) | 4.37 | 168815139<br> <sup>d</sup>  | **168815139** |
| **Investment of Cash Collateral for Securities Loaned - 2.8%**  | **Investment of Cash Collateral for Securities Loaned - 2.8%**  |  |  |
| **Registered Investment Companies - 2.8%** | **Registered Investment Companies - 2.8%** |  |  |
| Dreyfus Institutional Preferred Government Plus Money Market Fund, SL Shares<br>(cost $69,870,961) | 4.37 | 69870961<br> <sup>d</sup>  | **69870961** |
| **Total Investments** (cost $2,228,771,254) | **Total Investments** (cost $2,228,771,254) | **102.9%** | **2521752823** |
| **Liabilities, Less Cash and Receivables** | **Liabilities, Less Cash and Receivables** | **(2.9%)** | **(71057039)** |
| **Net Assets** | **Net Assets** | **100.0%** | **2450695784** |

---

*ADR—American Depository Receipt*

*<sup>a</sup> Security, or portion thereof, on loan. At December 31, 2022, the value of the fund's securities on loan was $144,435,111 and the value of the collateral was $149,272,449, consisting of cash collateral of $69,870,961 and U.S. Government & Agency securities valued at $79,401,488. In addition, the value of collateral may include pending sales that are also on loan.*

*<sup>b</sup> Non-income producing security.*

*<sup>c</sup> The fund held Level 3 securities at December 31, 2022. These securities were valued at $14,424,451 or .6% of net assets.*

*<sup>d</sup> Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's prospectus.*

------

STATEMENT OF INVESTMENTS<br>BNY Mellon Small/Mid Cap Growth Fund

December 31, 2022 (Unaudited)

The following is a summary of the inputs used as of December 31, 2022 in valuing the fund's investments:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Level 1-Unadjusted Quoted Prices | Level 2- Other Significant Observable Inputs | Level 3-Significant Unobservable Inputs | **Total** |
| **Assets ($)** | **Assets ($)** | **Assets ($)** | **Assets ($)** |  |
| Investments in Securities:<sup>†</sup> | Investments in Securities:<sup>†</sup> | Investments in Securities:<sup>†</sup> | Investments in Securities:<sup>†</sup> |  |
| Equity Securities - Common Stocks | 2268642272 | - | 163857 | **2268806129** |
| Equity Securities - Private Equity | - | - | 14260594 | **14260594** |
| Investment Companies | 238686100 | - | - | **238686100** |

---

*<sup>†</sup> See Statement of Investments for additional detailed categorizations, if any.*

------

The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") is the exclusive reference of authoritative U.S. generally accepted accounting principles ("GAAP") recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the SEC under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund's financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund's investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

**Level 1**—unadjusted quoted prices in active markets for identical investments.

**Level 2**—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

**Level 3**—significant unobservable inputs (including the fund's own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund's investments are as follows:

The Trust's Board of Trustees (the "Board") has designated the Adviser as the fund's valuation designee, effective September 8, 2022, to make all fair value determinations with respect to the fund's portfolio investments, subject to the Board's oversight and pursuant to Rule 2a-5 under the Act.

------

Investments in equity securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. U.S. Treasury Bills are valued at the mean price between quoted bid prices and asked prices by an independent pricing service (the "Service") approved by the Board Members ("Board"). These securities are generally categorized within Level 2 of the fair value hierarchy.The Service's procedures are reviewed by BNY Mellon under the general supervision of the Board.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depository Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

Pursuant to a securities lending agreement with The Bank of New York Mellon, a subsidiary of BNY Mellon and an affiliate of BNY Mellon Investment Adviser, Inc., the fund may lend securities to qualified institutions. It is the fund's policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value

------

of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by BNY Mellon Investment Adviser Inc., or U.S. Government and Agency securities. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a result of the lending transaction. Should a borrower fail to return the securities in a timely manner, The Bank of New York Mellon is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund's rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis.

At December 31, 2022, accumulated net unrealized appreciation on investments was $292,981,569, consisting of $621,371,310 gross unrealized appreciation and $328,389,741 gross unrealized depreciation.

At December 31, 2022, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** BNY Mellon Investment Funds I

- **b. Investment Company Act file number:** 811-04813

- **c. CIK number of Registrant:** 0000799295

- **d. LEI of Registrant:** 5493000M3XIJVKIWWS65

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 240 Greenwich Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10286

  - **Telephone number:** 212 495 1784

**Item A.2. Information about the Series.**

- **a. Name of Series:** BNY Mellon Small/Mid Cap Growth Fund

- **b. EDGAR series identifier (if any):** S000011499

- **c. LEI of Series:** 549300DP427BBILWFN87

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-09-30

- **b. Date as of which information is reported:** 2022-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $2453083189.82

**Total Liabilities:** $2387406.22

**Net Assets:** $2450695783.60

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000031760 | 7.53%                | 4.65%                | -5.40%               |
| Class ID C000075527 | 7.51%                | 4.64%                | -5.40%               |
| Class ID C000075528 | 7.43%                | 4.52%                | -5.44%               |
| Class ID C000130460 | 7.54%                | 4.65%                | -5.34%               |
| Class ID C000193013 | 7.51%                | 4.67%                | -5.38%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $38256954.36             | $146154361.14                              |
| Month 2  | $-16787487.83            | $135545748.97                              |
| Month 3  | $27223680.53             | $-168527293.15                             |

**Designated Index Information**

- **Index Name:** 0

- **Index Identifier:** 0

### Schedule of Portfolio Investments

| Name                                   | Title                                                             | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| MPMFUNDB3                              | Fundbox                                                           | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |    702664 | NS      | $2649043.28   | 0.11%             |  |  |  | No            |                  3 | On Loan: No      |
| MPMASPEN5                              | ASPEN NEUROSCI                                                    | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |   1963167 | NS      | $3965597.34   | 0.16%             |  |  |  | No            |                  2 | On Loan: No      |
| MPMROOFS3                              | ROOFSTOCK                                                         | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |    346123 | NS      | $3859271.45   | 0.16%             |  |  |  | No            |                  2 | On Loan: No      |
| 003CVR016                              | ABIOMED INC                                                       | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |    160644 | NS      | $163856.88    | 0.01%             |  |  |  | No            |                  2 | On Loan: No      |
| MPMLOCUS3                              | LOCUS ROBOTICS                                                    | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |    101086 | NS      | $3786681.56   | 0.15%             |  |  |  | No            |                  2 | On Loan: No      |
| BIOMARIN PHARMACEUTICAL INC            | BIOMARIN PHARMACEUTICAL INC                                       | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |    135507 | NS      | $14023619.43  | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC THERAPEUTICS INC                   | PTC THERAPEUTICS INC                                              | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |    465336 | NS      | $17761875.12  | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| DENALI THERAPEUTICS INC                | DENALI THERAPEUTICS INC                                           | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |    651477 | NS      | $18117575.37  | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| SAREPTA THERAPEUTICS INC               | SAREPTA THERAPEUTICS INC                                          | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |    756269 | NS      | $97997337.02  | 4.00%             |  |  |  | No            |                  1 | On Loan: No      |
| TRADEWEB MARKETS INC                   | TRADEWEB MARKETS INC                                              | CUSIP: 892672106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    328998 | NS      | $21361840.14  | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| 10X GENOMICS INC                       | 10X GENOMICS INC                                                  | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               | CORP              | US        |    309988 | NS      | $11295962.72  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| DOUBLEVERIFY HOLDINGS INC              | DOUBLEVERIFY HOLDINGS INC                                         | CUSIP: 25862V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    709426 | NS      | $15578994.96  | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| SHOPIFY INC                            | SHOPIFY INC                                                       | CUSIP: 82509L107<br>LEI: 549300HGQ43STJLLP808 | Long             | EC               | CORP              | CA        |    785574 | NS      | $27267273.54  | 1.11%             |  |  |  | No            |                  1 | On Loan: No      |
| COSTAR GROUP INC                       | COSTAR GROUP INC                                                  | CUSIP: 22160N109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    328229 | NS      | $25365537.12  | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| BURLINGTON STORES INC                  | BURLINGTON STORES INC                                             | CUSIP: 122017106<br>LEI: 5299003Z37DVGKKC1W09 | Long             | EC               | CORP              | US        |    121811 | NS      | $24698398.36  | 1.01%             |  |  |  | No            |                  1 | On Loan: No      |
| GROCERY OUTLET HOLDING CORP            | GROCERY OUTLET HOLDING CORP                                       | CUSIP: 39874R101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1757945 | NS      | $51314414.55  | 2.09%             |  |  |  | No            |                  1 | On Loan: No      |
| SEMTECH CORP                           | SEMTECH CORP                                                      | CUSIP: 816850101<br>LEI: 549300J7WUY317SW6O61 | Long             | EC               | CORP              | US        |    740142 | NS      | $21234673.98  | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| KYMERA THERAPEUTICS INC                | KYMERA THERAPEUTICS INC                                           | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    561008 | NS      | $14002759.68  | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| TRIMBLE INC                            | TRIMBLE INC                                                       | CUSIP: 896239100<br>LEI: 549300E2MI7NSZFQWS19 | Long             | EC               | CORP              | US        |    251911 | NS      | $12736620.16  | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| OUTSET MEDICAL INC                     | OUTSET MEDICAL INC                                                | CUSIP: 690145107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    467765 | NS      | $12077692.30  | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| POWER INTEGRATIONS INC                 | POWER INTEGRATIONS INC                                            | CUSIP: 739276103<br>LEI: 54930085LGXSCIHD5W31 | Long             | EC               | CORP              | US        |    472637 | NS      | $33897525.64  | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| LULULEMON ATHLETICA INC                | LULULEMON ATHLETICA INC                                           | CUSIP: 550021109<br>LEI: 549300D9GZ4BMLDW5T40 | Long             | EC               | CORP              | US        |    122532 | NS      | $39256802.16  | 1.60%             |  |  |  | No            |                  1 | On Loan: No      |
| ALIGN TECHNOLOGY INC                   | ALIGN TECHNOLOGY INC                                              | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |    269997 | NS      | $56942367.30  | 2.32%             |  |  |  | No            |                  1 | On Loan: No      |
| ZEBRA TECHNOLOGIES CORP                | ZEBRA TECHNOLOGIES CORP                                           | CUSIP: 989207105<br>LEI: PO0I32GKZ3HZMMDPZZ08 | Long             | EC               | CORP              | US        |     37876 | NS      | $9711785.16   | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| CACTUS INC                             | CACTUS INC                                                        | CUSIP: 127203107<br>LEI: 549300J3T8C9F8QFKV08 | Long             | EC               | CORP              | US        |   1152119 | NS      | $57905500.94  | 2.36%             |  |  |  | No            |                  1 | On Loan: No      |
| ARES MANAGEMENT CORP                   | ARES MANAGEMENT CORP                                              | CUSIP: 03990B101<br>LEI: 529900JUV61FH7B8VW38 | Long             | EC               | CORP              | US        |    273835 | NS      | $18741267.40  | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| INSMED INC                             | INSMED INC                                                        | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |    544661 | NS      | $10882326.78  | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| BANDWIDTH INC                          | BANDWIDTH INC                                                     | CUSIP: 05988J103<br>LEI: 549300QC70JB7MUGXM66 | Long             | EC               | CORP              | US        |    443755 | NS      | $10184177.25  | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| LIVE NATION ENTERTAINMENT INC          | LIVE NATION ENTERTAINMENT INC                                     | CUSIP: 538034109<br>LEI: 5493007B9BM9ZXJINO78 | Long             | EC               | CORP              | US        |    345955 | NS      | $24126901.70  | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| AZEK CO INC/THE                        | AZEK CO INC/THE                                                   | CUSIP: 05478C105<br>LEI: 5493002LDDDU1RX46815 | Long             | EC               | CORP              | US        |    513963 | NS      | $10443728.16  | 0.43%             |  |  |  | No            |                  1 | On Loan: —       |
| EXPEDIA GROUP INC                      | EXPEDIA GROUP INC                                                 | CUSIP: 30212P303<br>LEI: CI7MUJI4USF3V0NJ1H64 | Long             | EC               | CORP              | US        |    480960 | NS      | $42132096.00  | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| INSPIRE MEDICAL SYSTEMS INC            | INSPIRE MEDICAL SYSTEMS INC                                       | CUSIP: 457730109<br>LEI: 549300XQQCQ7HCJKTW25 | Long             | EC               | CORP              | US        |     96250 | NS      | $24243450.00  | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| INSULET CORP                           | INSULET CORP                                                      | CUSIP: 45784P101<br>LEI: 549300TZTYD2PYN92D43 | Long             | EC               | CORP              | US        |     64768 | NS      | $19067051.52  | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| FRESHPET INC                           | FRESHPET INC                                                      | CUSIP: 358039105<br>LEI: 549300S4ZK8ZQ6HNPN59 | Long             | EC               | CORP              | US        |    714599 | NS      | $37709389.23  | 1.54%             |  |  |  | No            |                  1 | On Loan: —       |
| HUBSPOT INC                            | HUBSPOT INC                                                       | CUSIP: 443573100<br>LEI: 529900BLNVEW0MVKJB37 | Long             | EC               | CORP              | US        |    171425 | NS      | $49564110.25  | 2.02%             |  |  |  | No            |                  1 | On Loan: No      |
| DOCUSIGN INC                           | DOCUSIGN INC                                                      | CUSIP: 256163106<br>LEI: 549300Q7PVDWRZ39JG09 | Long             | EC               | CORP              | US        |    121716 | NS      | $6745500.72   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| ALCOA CORP                             | ALCOA CORP                                                        | CUSIP: 013872106<br>LEI: 549300T12EZ1F6PWWU29 | Long             | EC               | CORP              | US        |    560302 | NS      | $25476931.94  | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| SPLUNK INC                             | SPLUNK INC                                                        | CUSIP: 848637104<br>LEI: 549300XGDSGBP6UEI867 | Long             | EC               | CORP              | US        |    236225 | NS      | $20336610.25  | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| HORIZON THERAPEUTICS PLC               | HORIZON THERAPEUTICS PLC                                          | CUSIP: N/A<br>LEI: 529900P0GSQ79OOZEV53       | Long             | EC               | CORP              | US        |    696704 | NS      | $79284915.20  | 3.24%             |  |  |  | No            |                  1 | On Loan: No      |
| CYTOKINETICS INC                       | CYTOKINETICS INC                                                  | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |    277377 | NS      | $12709414.14  | 0.52%             |  |  |  | No            |                  1 | On Loan: —       |
| FLUOR CORP                             | FLUOR CORP                                                        | CUSIP: 343412102<br>LEI: CQ7WZ4NOFWT7FAE6Q943 | Long             | EC               | CORP              | US        |   1024368 | NS      | $35504594.88  | 1.45%             |  |  |  | No            |                  1 | On Loan: —       |
| ULTRAGENYX PHARMACEUTICAL INC          | ULTRAGENYX PHARMACEUTICAL INC                                     | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |    290227 | NS      | $13446216.91  | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| BEAM THERAPEUTICS INC                  | BEAM THERAPEUTICS INC                                             | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    146289 | NS      | $5721362.79   | 0.23%             |  |  |  | No            |                  1 | On Loan: —       |
| CACI INTERNATIONAL INC                 | CACI INTERNATIONAL INC                                            | CUSIP: 127190304<br>LEI: SYRPI2D1O9WRTS2WX210 | Long             | EC               | CORP              | US        |    148185 | NS      | $44542929.15  | 1.82%             |  |  |  | No            |                  1 | On Loan: No      |
| REPLIGEN CORP                          | REPLIGEN CORP                                                     | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |    253087 | NS      | $42850159.97  | 1.75%             |  |  |  | No            |                  1 | On Loan: —       |
| CLARIVATE PLC                          | CLARIVATE PLC                                                     | CUSIP: N/A<br>LEI: 549300WDHIIODXFO0R55       | Long             | EC               | CORP              | JE        |   1344385 | NS      | $11212170.90  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| ASCENDIS PHARMA A/S                    | ASCENDIS PHARMA A/S                                               | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |    185027 | NS      | $22597347.51  | 0.92%             |  |  |  | No            |                  1 | On Loan: —       |
| AVIDXCHANGE HOLDINGS INC               | AVIDXCHANGE HOLDINGS INC                                          | CUSIP: 05368X102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    517628 | NS      | $5145222.32   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| CALIX INC                              | CALIX INC                                                         | CUSIP: 13100M509<br>LEI: 5299002RQRZ4SXSCSJ58 | Long             | EC               | CORP              | US        |    514794 | NS      | $35227353.42  | 1.44%             |  |  |  | No            |                  1 | On Loan: No      |
| KARUNA THERAPEUTICS INC                | KARUNA THERAPEUTICS INC                                           | CUSIP: 48576A100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     60584 | NS      | $11904756.00  | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| LIBERTY MEDIA CORP-LIBERTY FORMULA ONE | LIBERTY MEDIA CORP-LIBERTY FORMULA ONE                            | CUSIP: 531229854<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    690528 | NS      | $41279763.84  | 1.68%             |  |  |  | No            |                  1 | On Loan: No      |
| R1 RCM INC                             | R1 RCM INC                                                        | CUSIP: 77634L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    989752 | NS      | $10837784.40  | 0.44%             |  |  |  | No            |                  1 | On Loan: —       |
| NLIGHT INC                             | NLIGHT INC                                                        | CUSIP: 65487K100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    602269 | NS      | $6107007.66   | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| TWILIO INC                             | TWILIO INC                                                        | CUSIP: 90138F102<br>LEI: 5493004W8TRGD63APX93 | Long             | EC               | CORP              | US        |   1212562 | NS      | $59367035.52  | 2.42%             |  |  |  | No            |                  1 | On Loan: No      |
| DIGITALOCEAN HOLDINGS INC              | DIGITALOCEAN HOLDINGS INC                                         | CUSIP: 25402D102<br>LEI: 549300EPISPY3RE3DL21 | Long             | EC               | CORP              | US        |    576726 | NS      | $14689211.22  | 0.60%             |  |  |  | No            |                  1 | On Loan: —       |
| CHEWY INC                              | CHEWY INC                                                         | CUSIP: 16679L109<br>LEI: 254900NPQSTG9I422879 | Long             | EC               | CORP              | US        |    661803 | NS      | $24539655.24  | 1.00%             |  |  |  | No            |                  1 | On Loan: —       |
| PRIVIA HEALTH GROUP INC                | PRIVIA HEALTH GROUP INC                                           | CUSIP: 74276R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1616137 | NS      | $36702471.27  | 1.50%             |  |  |  | No            |                  1 | On Loan: —       |
| CONSTELLIUM SE                         | CONSTELLIUM SE                                                    | CUSIP: N/A<br>LEI: 724500KRJEMC79KAAU28       | Long             | EC               | CORP              | FR        |   1804001 | NS      | $21341331.83  | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| MERCURY SYSTEMS INC                    | MERCURY SYSTEMS INC                                               | CUSIP: 589378108<br>LEI: 549300P3B84SGK7HH679 | Long             | EC               | CORP              | US        |    769919 | NS      | $34446176.06  | 1.41%             |  |  |  | No            |                  1 | On Loan: —       |
| PLANET FITNESS INC                     | PLANET FITNESS INC                                                | CUSIP: 72703H101<br>LEI: 549300LLE5HUPF6H8G33 | Long             | EC               | CORP              | US        |   1081614 | NS      | $85231183.20  | 3.48%             |  |  |  | No            |                  1 | On Loan: No      |
| EUROPEAN WAX CENTER INC                | EUROPEAN WAX CENTER INC                                           | CUSIP: 29882P106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    565615 | NS      | $7041906.75   | 0.29%             |  |  |  | No            |                  1 | On Loan: —       |
| BLOCK INC                              | BLOCK INC                                                         | CUSIP: 852234103<br>LEI: 549300OHIIUWSTIZME52 | Long             | EC               | CORP              | US        |    289334 | NS      | $18181748.56  | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| PBF ENERGY INC                         | PBF ENERGY INC                                                    | CUSIP: 69318G106<br>LEI: 2549003PBEDCSZMZIY02 | Long             | EC               | CORP              | US        |    734970 | NS      | $29972076.60  | 1.22%             |  |  |  | No            |                  1 | On Loan: No      |
| OLLIE'S BARGAIN OUTLET HOLDINGS INC    | OLLIE'S BARGAIN OUTLET HOLDINGS INC                               | CUSIP: 681116109<br>LEI: 529900YO5DSQCPEFDZ05 | Long             | EC               | CORP              | US        |   1170705 | NS      | $54835822.20  | 2.24%             |  |  |  | No            |                  1 | On Loan: No      |
| ARMSTRONG WORLD INDUSTRIES INC         | ARMSTRONG WORLD INDUSTRIES INC                                    | CUSIP: 04247X102<br>LEI: KXMRXXOJ88Q45Y45MG74 | Long             | EC               | CORP              | US        |    379725 | NS      | $26045337.75  | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| CURTISS-WRIGHT CORP                    | CURTISS-WRIGHT CORP                                               | CUSIP: 231561101<br>LEI: TEL51ETZWP7D0ZM4X325 | Long             | EC               | CORP              | US        |    180891 | NS      | $30206988.09  | 1.23%             |  |  |  | No            |                  1 | On Loan: No      |
| FTI CONSULTING INC                     | FTI CONSULTING INC                                                | CUSIP: 302941109<br>LEI: 549300K17GM8EQD0FQ48 | Long             | EC               | CORP              | US        |    152354 | NS      | $24193815.20  | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| EVERBRIDGE INC                         | EVERBRIDGE INC                                                    | CUSIP: 29978A104<br>LEI: 549300WCY0UMR64ATW81 | Long             | EC               | CORP              | US        |    369805 | NS      | $10938831.90  | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| NEUROCRINE BIOSCIENCES INC             | NEUROCRINE BIOSCIENCES INC                                        | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |    353100 | NS      | $42174264.00  | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| BIO-TECHNE CORP                        | BIO-TECHNE CORP                                                   | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |    464051 | NS      | $38460546.88  | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| TWIST BIOSCIENCE CORP                  | TWIST BIOSCIENCE CORP                                             | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |    381918 | NS      | $9093467.58   | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| EQT CORP                               | EQT CORP                                                          | CUSIP: 26884L109<br>LEI: 4NT01YGM4X7ZX86ISY52 | Long             | EC               | CORP              | US        |   1996270 | NS      | $67533814.10  | 2.76%             |  |  |  | No            |                  1 | On Loan: No      |
| EURONET WORLDWIDE INC                  | EURONET WORLDWIDE INC                                             | CUSIP: 298736109<br>LEI: YG3575C4DSHJPA5KET68 | Long             | EC               | CORP              | US        |    379866 | NS      | $35851753.08  | 1.46%             |  |  |  | No            |                  1 | On Loan: No      |
| GRACO INC                              | GRACO INC                                                         | CUSIP: 384109104<br>LEI: 4T5VJ4S81BRT6Q7GGT78 | Long             | EC               | CORP              | US        |    333354 | NS      | $22421390.04  | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| BILL.COM HOLDINGS INC                  | BILL.COM HOLDINGS INC                                             | CUSIP: 090043100<br>LEI: 549300IBF9VZZIGOZW63 | Long             | EC               | CORP              | US        |    302217 | NS      | $32929564.32  | 1.34%             |  |  |  | No            |                  1 | On Loan: No      |
| 1LIFE HEALTHCARE INC                   | 1LIFE HEALTHCARE INC                                              | CUSIP: 68269G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1575410 | NS      | $26325101.10  | 1.07%             |  |  |  | No            |                  1 | On Loan: No      |
| NCINO INC                              | NCINO INC                                                         | CUSIP: 63947X101<br>LEI: 549300WVRR2WR3L6MZ46 | Long             | EC               | CORP              | US        |    319062 | NS      | $8435999.28   | 0.34%             |  |  |  | No            |                  1 | On Loan: —       |
| ZURN ELKAY WATER SOLUTIONS CORP        | ZURN ELKAY WATER SOLUTIONS CORP                                   | CUSIP: 98983L108<br>LEI: 549300AM3633XDFU1Q85 | Long             | EC               | CORP              | US        |    451294 | NS      | $9544868.10   | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| DEXCOM INC                             | DEXCOM INC                                                        | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |    737682 | NS      | $83535109.68  | 3.41%             |  |  |  | No            |                  1 | On Loan: No      |
| NATIONAL VISION HOLDINGS INC           | NATIONAL VISION HOLDINGS INC                                      | CUSIP: 63845R107<br>LEI: 549300JHURCBLI5ROA42 | Long             | EC               | CORP              | US        |   1108209 | NS      | $42954180.84  | 1.75%             |  |  |  | No            |                  1 | On Loan: —       |
| FARFETCH LTD                           | FARFETCH LTD                                                      | CUSIP: 30744W107<br>LEI: 549300QFQ74Z0F96NS78 | Long             | EC               | CORP              | KY        |   4355596 | NS      | $20601969.08  | 0.84%             |  |  |  | No            |                  1 | On Loan: —       |
| MORNINGSTAR INC                        | MORNINGSTAR INC                                                   | CUSIP: 617700109<br>LEI: 529900YGNQPOVAXQ7F29 | Long             | EC               | CORP              | US        |    144628 | NS      | $31324978.52  | 1.28%             |  |  |  | No            |                  1 | On Loan: No      |
| SITEONE LANDSCAPE SUPPLY INC           | SITEONE LANDSCAPE SUPPLY INC                                      | CUSIP: 82982L103<br>LEI: 5299008LX7SBD4HIAU03 | Long             | EC               | CORP              | US        |     96220 | NS      | $11288530.40  | 0.46%             |  |  |  | No            |                  1 | On Loan: —       |
| LUMENTUM HOLDINGS INC                  | LUMENTUM HOLDINGS INC                                             | CUSIP: 55024U109<br>LEI: 549300JLWRRC38DWEF52 | Long             | EC               | CORP              | US        |    409390 | NS      | $21357876.30  | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| PELOTON INTERACTIVE INC                | PELOTON INTERACTIVE INC                                           | CUSIP: 70614W100<br>LEI: 5493002YS021166W0339 | Long             | EC               | CORP              | US        |   3337805 | NS      | $26502171.70  | 1.08%             |  |  |  | No            |                  1 | On Loan: —       |
| DREYFUS INSTITUTIONAL PREFERRE         | Dreyfus Institutional Preferred Government Plus Money Market Fund | CUSIP: N/A<br>LEI: 549300RBWL04JG8SIX57       | Long             | STIV             | RF                | US        | 168815139 | OU      | $168815139.40 | 6.89%             | 2099-12-01      | Variable      | 4.37%                 | No            |                  1 | On Loan: No      |
| 99VVB9HH4                              | DREYFUS INST PREF GOVT PLUS-SL #4134                              | CUSIP: 99VVB9HH4<br>LEI: N/A                  | Long             |  | RF                | US        |  69880344 | OU      | $69880344.46  | 2.85%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-02-23

**Name of Applicant:** BNY Mellon Advantage Funds, Inc.

**Signature:** James Windels

**Name of Signer:** James Windels

**Title:** Fund Treasurer